Claudio Laquatra

548 total citations
10 papers, 337 citations indexed

About

Claudio Laquatra is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Claudio Laquatra has authored 10 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Claudio Laquatra's work include Mitochondrial Function and Pathology (5 papers), ATP Synthase and ATPases Research (5 papers) and Heat shock proteins research (3 papers). Claudio Laquatra is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), ATP Synthase and ATPases Research (5 papers) and Heat shock proteins research (3 papers). Claudio Laquatra collaborates with scholars based in Italy and Denmark. Claudio Laquatra's co-authors include Andrea Rasola, Ionica Masgras, Francesco Ciscato, Giorgio Colombo, Giuseppe Cannino, Carlos Sànchez‐Martìn, Elisabetta Moroni, Mariarosaria Ferraro, Francesco Argenton and Alessandro Negro and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Cell Reports.

In The Last Decade

Claudio Laquatra

9 papers receiving 337 citations

Peers

Claudio Laquatra
Rigney E. Turnham United States
Boh-Ram Kim South Korea
Clint A. Stalnecker United States
Mahlet Abera United States
Rigney E. Turnham United States
Claudio Laquatra
Citations per year, relative to Claudio Laquatra Claudio Laquatra (= 1×) peers Rigney E. Turnham

Countries citing papers authored by Claudio Laquatra

Since Specialization
Citations

This map shows the geographic impact of Claudio Laquatra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Laquatra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Laquatra more than expected).

Fields of papers citing papers by Claudio Laquatra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Laquatra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Laquatra. The network helps show where Claudio Laquatra may publish in the future.

Co-authorship network of co-authors of Claudio Laquatra

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Laquatra. A scholar is included among the top collaborators of Claudio Laquatra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Laquatra. Claudio Laquatra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Faienza, Fiorella, Claudio Laquatra, Matteo Castelli, et al.. (2025). Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities. Redox Biology. 84. 103677–103677. 1 indexed citations
2.
Laquatra, Claudio, Albert M. Magro, Matteo Lambrughi, et al.. (2025). Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity. Cell Death and Disease. 16(1). 172–172. 2 indexed citations
3.
Masgras, Ionica, Francesco Ciscato, Claudio Laquatra, et al.. (2024). Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors. Journal of Chemical Information and Modeling. 64(21). 8274–8282.
4.
Dinarello, Alberto, Riccardo Massimiliano Betto, Giacomo Meneghetti, et al.. (2023). STAT3 and HIF1α cooperatively mediate the transcriptional and physiological responses to hypoxia. Cell Death Discovery. 9(1). 226–226. 23 indexed citations
5.
Ciscato, Francesco, et al.. (2021). Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters. International Journal of Molecular Sciences. 22(9). 4716–4716. 158 indexed citations
6.
Masgras, Ionica, Claudio Laquatra, Giuseppe Cannino, et al.. (2021). The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting. Seminars in Cancer Biology. 76. 45–53. 29 indexed citations
7.
Laquatra, Claudio, Carlos Sànchez‐Martìn, Alberto Dinarello, et al.. (2021). HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. Cell Death and Disease. 12(5). 434–434. 25 indexed citations
8.
Carrer, Andrea, et al.. (2021). Modulation and Pharmacology of the Mitochondrial Permeability Transition: A Journey from F-ATP Synthase to ANT. Molecules. 26(21). 6463–6463. 10 indexed citations
9.
Sànchez‐Martìn, Carlos, Elisabetta Moroni, Mariarosaria Ferraro, et al.. (2020). Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1. Cell Reports. 31(3). 107531–107531. 64 indexed citations
10.
Laquatra, Claudio, Nicola Facchinello, Giacomo Meneghetti, et al.. (2019). The zebrafish orthologue of the human hepatocerebral disease geneMPV17plays pleiotropic roles in mitochondria. Disease Models & Mechanisms. 12(3). 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026